Millipore Sigma Vibrant Logo

MABF227 Anti-Interferon Lambda 4, clone 4G1 Antibody

View Products on Sigmaaldrich.com
MABF227
100 µg  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Offres spéciales

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Offres spéciales

      Tableau de caractéristiques principal

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, NhPELISA, FC, ICC, IHC, WBMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABF227
      DescriptionAnti-Interferon Lambda 4, clone 4G1 Antibody
      Alternate Names
      • Interferon lambda-4
      • IFN-lambda-4
      Background InformationInterferon Lambda 4, also known as IFN-lambda-4, and encoded by the gene IFNL4, is an important cytokine that forms part of our innate immunity against viruses. Interferon lambda-4 activates the JAK-STAT signaling pathway and ultimately up regulates several interferon specific stimulated genes. Interferon lambda-4 expression can be stimulated by nucleotide strands particularly ployinosinic-polycytidylic acid (polyI:C) which mimics the double-stranded hepatitis C virus. A genetic variation in the Interferon lambda-4 gene is associated with susceptibility to HCV infection. The mutation of a single base insertion results in gene inactivation resulting in defective immune response to HCV. Interferon lambda-4 signaling operates through Interferon lambda R1 and IL-10R2 receptors and the mutation is associated with defective glycosylation which is required for secretion, thus the amplification of the signal becomes compromised resulting in susceptibility to HCV as well as coronaviruses.
      References
      Product Information
      FormatPurified
      PresentationPurified mouse IgG1κ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationThis Anti-Interferon Lambda 4 antibody, clone 4G1 is validated for use in ELISA, Flow Cytometry, Immunocytochemistry, Immunohistochemistry, and Western Blotting for the detection of Interferon Lambda 4.
      Key Applications
      • ELISA
      • Flow Cytometry
      • Immunocytochemistry
      • Immunohistochemistry
      • Western Blotting
      Application NotesImmunohistochemistry Analysis: A 1:50 dilution from a representative lot detected Interferon Lambda 4 in human and rat liver tissue sections.

      ELISA Analysis: A representative lot was conjugated with a sulfo-tag (MSD) and employed as the detection antibody in a sandwich ELISA application. An exogenously expressed IFNL4 HaloTag® fusion was found secreted in the culture media from IFNL4-Halo construct-transfected, but not mock-transfected HepG2 cells (Onabajo, O.O., et al. (2015). J. Interferon. Cytokine Res. 35(11):888-900).

      Flow Cytometry Analysis: A representative lot immunostained HepG2 cells transfected to express HaloTag® fusion IFN-λ4 orthologs of elephant, human and non-human primate (chimpanzee, orangutan, rhesus, marmoset, cynomolgus) origins, but not cells expressing IFNL4 of bovine, bat, canine, panda, and porcine species (Paquin, A., et al. (2016). J. Interferon Cytokine Res. 36(1):30-36).

      Immunocytochemistry Analysis: Representative lots immunostained HepG2 cells transfected to express HaloTag® fusion of IFN-λ4 orthologs of elephant, human and non-human primate (chimpanzee, orangutan, rhesus, marmoset, cynomolgus) origins (Paquin, A., et al. (2016). J. Interferon Cytokine Res. 36(1):30-36; Prokunina-Olsson, L., et al. (2013). Nat. Genet. 45(2):164-171).

      Immunocytochemistry Analysis: A representative lot detected a time-dependent induction of IFNL4 expression in hepatocytes from a donor heterozygous for ss469415590 (TT/ΔG) upon PolyI:C treatment or hepatitis C virus (HCV) strain JFH1HCV infection in cultures (Prokunina-Olsson, L., et al. (2013). Nat. Genet. 45(2):164-171).

      Western Blotting Analysis: A representative lot detected HaloTag® fusion IFN-λ4 orthologs of elephant, human and non-human primate (chimpanzee, orangutan, rhesus, marmoset, cynomolgus) origins, but not IFNL4 of bovine, bat, canine, panda, and porcine species transiently expressed in HepG2 cells (Paquin, A., et al. (2016). J. Interferon Cytokine Res. 36(1):30-36).

      Western Blotting Analysis: A representative lot detected exogenously expressed IFNL4 HaloTag® fusion constructs in transfected COS-7 and HepG2 cells, but not in untransfected cells. Clone 4G1 does not cross-react with IFN-alpha or IL-28B (Prokunina-Olsson, L., et al. (2013). Nat. Genet. 45(2):164-171).
      Biological Information
      ImmunogenLinear peptide corresponding to an internal sequence from the N-termninal half of human interferon lambda 4.
      EpitopeInternal (N-terminal half).
      Clone4G1
      Concentration1 mg/mL
      HostMouse
      SpecificityClone 4G1 detected IFNL4 expression induction in primary hepatocytes (e.g. by PolyIC or by HCV) and exogenously overexpressed IFNL4 in HepG2 cells. IFNL4 expression is not detectable in normal liver cells (Dr. Ludmila Prokunina-Olsson, National Cancer Institute, NIH, Bethesda, MD). Clone 4G1 does not cross-react with IFN-alpha or IL-28B (Prokunina-Olsson, L., et al. (2013). Nat. Genet. 45(2):164-171).
      IsotypeIgG1κ
      Species Reactivity
      • Human
      • Non-human Primate
      Species Reactivity NoteHuman, Non-Human Primate. Not Bovine, Bat, Canine, Panda, or Porcine.
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • IFNL4
      Purification MethodProtein G Purified
      UniProt Number
      Molecular Weight~21 kDa observed.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blotting of human IFNL4 recombinant protein.

      Western Blotting Analysis: 1.0 µg/mL of this antibody detected 0.1 µg of human IFNL4 recombinant protein.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      MABF227 04053252976339

      Documentation

      Anti-Interferon Lambda 4, clone 4G1 Antibody FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Anti-Interferon Lambda 4, clone 4G1 Antibody Certificats d'analyse

      TitreNuméro de lot
      Anti-Interferon Lambda 4, clone 4G1 - 3221521 3221521
      Anti-Interferon Lambda 4, clone 4G1 - 3668157 3668157
      Anti-Interferon Lambda 4, clone 4G1 - 3994022 3994022
      Anti-Interferon Lambda 4, clone 4G1 -2523221 2523221
      Anti-Interferon Lambda 4, clone 4G1 -2618511 2618511
      Anti-Interferon Lambda 4, clone 4G1 -2668548 2668548
      Anti-Interferon Lambda 4, clone 4G1 -2683306 2683306
      Anti-Interferon Lambda 4, clone 4G1 -2733290 2733290
      Anti-Interferon Lambda 4, clone 4G1 -2855616 2855616
      Anti-Interferon Lambda 4, clone 4G1 Monoclonal Antibody 2930199

      Références bibliographiques

      Aperçu de la référence bibliographiqueNº PubMed
      A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.
      Prokunina-Olsson, Ludmila, et al.
      Nat. Genet., 45: 164-71 (2013)  2013

      Afficher le résumé
      23291588 23291588

      Brochure

      Titre
      New Products - Antibodies, Assays, Small Molecules, Inhibitors, and Proteins Volume 2, 2014